Income Taxes (Details) - USD ($) $ in Thousands |
1 Months Ended | 3 Months Ended | 9 Months Ended | |||||
|---|---|---|---|---|---|---|---|---|
Feb. 15, 2023 |
Jun. 30, 2023 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Dec. 31, 2022 |
|
| Operating Loss Carryforwards [Line Items] | ||||||||
| Loss before income taxes | $ (10,640) | $ (9,873) | $ (45,259) | $ (36,791) | ||||
| Income tax benefit (expense) | $ 1,977 | $ (5,818) | $ 3,393 | $ 2,412 | ||||
| Effective tax rate | 19.00% | 59.00% | 7.00% | 7.00% | ||||
| Gain(loss) on sale of assets | $ 8,401 | $ (1) | ||||||
| Investments | $ 1 | $ 1 | $ 6,402 | |||||
| HERBL, Inc. | ||||||||
| Operating Loss Carryforwards [Line Items] | ||||||||
| Investment impairment | $ 6,400 | $ 6,400 | ||||||
| Investments | $ 0 | $ 0 | $ 0 | $ 0 | 6,400 | |||
| Capital Loss Carryforward Member | ||||||||
| Operating Loss Carryforwards [Line Items] | ||||||||
| Gain(loss) on sale of assets | $ 6,264 | |||||||
| U.S. federal | Capital Loss Carryforward Member | ||||||||
| Operating Loss Carryforwards [Line Items] | ||||||||
| Capital loss carryforward | 31,971 | |||||||
| U.S. state and local | Capital Loss Carryforward Member | ||||||||
| Operating Loss Carryforwards [Line Items] | ||||||||
| Capital loss carryforward | $ 18,968 | |||||||
| X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|